Aadi Bioscience Raises $23M
socalTECH
MAY 8, 2017
Pacific Palisades-based Aadi Bioscience , a biopharmaceuticals firm focused on diseases related to mTOR activation, said it has raised $23M in a Series A funding round. Aadi Bioscience licensed the technology for its biopharmaceuticals from Celgene in 2014. READ MORE>>.
Let's personalize your content